These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1817 related articles for article (PubMed ID: 22437871)
21. Dendritic cell vaccines for cancer immunotherapy. Timmerman JM; Levy R Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291 [TBL] [Abstract][Full Text] [Related]
22. Dendritic cells: a critical player in cancer therapy? Palucka AK; Ueno H; Fay J; Banchereau J J Immunother; 2008; 31(9):793-805. PubMed ID: 18833008 [TBL] [Abstract][Full Text] [Related]
23. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen. Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656 [TBL] [Abstract][Full Text] [Related]
24. Dendritic cell biology and its role in tumor immunotherapy. Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880 [TBL] [Abstract][Full Text] [Related]
25. Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses. Vermaelen K Front Immunol; 2019; 10():8. PubMed ID: 30723469 [TBL] [Abstract][Full Text] [Related]
26. The use of dendritic cells in cancer immunotherapy. Schuler G; Schuler-Thurner B; Steinman RM Curr Opin Immunol; 2003 Apr; 15(2):138-47. PubMed ID: 12633662 [TBL] [Abstract][Full Text] [Related]
28. The dendritic cell and human cancer vaccines. Dallal RM; Lotze MT Curr Opin Immunol; 2000 Oct; 12(5):583-8. PubMed ID: 11007363 [TBL] [Abstract][Full Text] [Related]
29. Cancer immunotherapy by fusions of dendritic cells and tumor cells. Koido S; Hara E; Homma S; Ohkusa T; Gong J; Tajiri H Immunotherapy; 2009 Jan; 1(1):49-62. PubMed ID: 20635973 [TBL] [Abstract][Full Text] [Related]
30. Dendritic cells in cancer immunotherapy. Schuler G Eur J Immunol; 2010 Aug; 40(8):2123-30. PubMed ID: 20853498 [TBL] [Abstract][Full Text] [Related]
31. Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines. Saxena M; Bhardwaj N Curr Opin Immunol; 2017 Aug; 47():35-43. PubMed ID: 28732279 [TBL] [Abstract][Full Text] [Related]
32. Dendritic cell biology and cancer therapy. Whiteside TL; Odoux C Cancer Immunol Immunother; 2004 Mar; 53(3):240-8. PubMed ID: 14685779 [TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy. Zhu S; Yang N; Wu J; Wang X; Wang W; Liu YJ; Chen J Pharmacol Res; 2020 Sep; 159():104980. PubMed ID: 32504832 [TBL] [Abstract][Full Text] [Related]
34. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Galati D; Zanotta S Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963 [TBL] [Abstract][Full Text] [Related]
35. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond. Bol KF; Schreibelt G; Gerritsen WR; de Vries IJ; Figdor CG Clin Cancer Res; 2016 Apr; 22(8):1897-906. PubMed ID: 27084743 [TBL] [Abstract][Full Text] [Related]
37. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. Markiewicz MA; Kast WM Cancer Invest; 2004; 22(3):417-34. PubMed ID: 15493363 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cells as therapeutic vaccines against cancer. Banchereau J; Palucka AK Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149 [TBL] [Abstract][Full Text] [Related]
39. Dendritic cells as vectors for immunotherapy of cancer. Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163 [TBL] [Abstract][Full Text] [Related]
40. Dendritic cells and cytokines in immune rejection of cancer. Ferrantini M; Capone I; Belardelli F Cytokine Growth Factor Rev; 2008 Feb; 19(1):93-107. PubMed ID: 18054517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]